Number of the records: 1
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
- 1.
SYSNO 0505825 Title Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? Author(s) Funda, David P. (MBU-M) RID, ORCID
Palová-Jelinková, L. (CZ)
Goliáš, Jaroslav (MBU-M) RID
Kroulíková, Zuzana (MBU-M)
Fajstová, Alena (MBU-M) ORCID
Hudcovic, Tomáš (MBU-M) RID, ORCID
Spíšek, R. (CZ)Corespondence/senior Funda, David P. - Korespondující autor Source Title Frontiers in Immunology. Roč. 10, MAY 14 (2019). - : Frontiers Media Article number 967 Document Type Článek v odborném periodiku Grant NV16-27994A GA MZd - Ministry of Health (MZ), CZ - Czech Republic Institutional support MBU-M - RVO:61388971 Language eng Country CH Keywords type 1 diabetes * cell therapy * animal models Cooperating institutions Sotio AS, Praha (Czech Republic)
Univerzita Karlova v Praze (Czech Republic)URL https://www.frontiersin.org/articles/10.3389/fimmu.2019.00967/full Permanent Link http://hdl.handle.net/11104/0297201 File Download Size Commentary Version Access 151-Optimal Tolerogenic Dendritic Cells.pdf 5 2.1 MB Publisher’s postprint require
Number of the records: 1